Biocompatibility of a new cell separator studied by flow cytometry: Analyses of platelet antigens during apheresis and storage

Transfusion

Volumn 39, Issue 7, 1999, Pages 742-747

  Gutensohn, K ^a   Alisch, A ^b   Crespeigne, N ^b   Eifrig, B ^b   Kuehnl, P ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; THROMBOCYTE ANTIGEN;

ADULT; ARTICLE; BIOCOMPATIBILITY; CELL SEPARATION; CONTAINER; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; MALE; NORMAL HUMAN; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS;

ADULT; ANTIGENS; BIOCOMPATIBLE MATERIALS; BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; BLOOD PRESERVATION; CELL SEPARATION; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; HUMANS; MALE; PROTEIN BINDING; TIME FACTORS;

EID: 0032799670     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39070742.x     Document Type: Article

References (45)

1. Slichter SJ. Platelet transfusion therapy. Hematol Oncol Clin North Am 1990;4:291-311.
2. Murphy MF. Clinical aspects of platelet transfusion therapy. Infusionsther Transfusionsmed 1994;21:34-8.
3. Council of Europe. Guide to the use, preparation and quality control of blood components. 3rd ed. Strasbourg: Council of Europe Publishing, 1997.
4. Quality assurance in blood establishments. Docket No. 91N-0450 ed. Rockville, MD: FDA, 1993.
5. Standards for blood banks and transfusion services. 16th ed. Bethesda: American Association of Blood Banks, 1994.
6. Foley J, Min K, Peters S, et al. Enhanced platelet collection efficiency using a new blood cell separator (abstract). Transfusion 1995;35(Suppl):3S.
7. Version 1.4 (user manual). Deerfield, IL: Fenwal Division, Baxter Healthcare Corporation, 1997.
8. Brown R, Cork W, Giesler R, et al. High efficiency mass transport in the platelet separation and collection stages of the AMICUS™ cell separator (abstract). Presented at the 5th Regional Congress of the ISBT, Venice, Italy, July 2-5, 1995:307.
9. Garratty G, Arndt P. Applications of flow cytofluorometry to transfusion science. Transfusion 1995;35:157-78.
10. Gutensohn K, Kuehnl P. Flow cytometry in modern transfusion medicine. Clin Lab 1997;43:83-90.
11. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies. Blood 1987;70:307-15.
12. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996;87:4925-36.
13. Gutensohn K, Bartsch N, Kuehnl P. Flow cytometric analysis of platelet membrane antigens during and after continuous-flow plateletpheresis. Transfusion 1997;37:809-15.
14. Ratner BD. The blood compatibility catastrophe. J Biomed Mater Res 1993;27:283-7.
15. Haycox CL, Ratner BD. In vitro platelet interactions in whole human blood exposed to biomaterial surfaces: insights in blood compatibility. J Biomed Mater Res 1993;27:1181-93.
16. Kaplan KL, Owen J. Radioimmunoassays of platelet alpha granule proteins. In: Harker LA, Zimmermann TS, eds. Measurements of platelet function. New York: Churchill Livingstone, 1983:115-21.
17. 2 formation. N Engl J Med 1988;319:761-7.
18. Kinlough-Rathbone RL, Packham MA, Nustard JF. Platelet aggregation. In: Harker LA, Zimmermann TS, eds. Measurements of platelet function. New York: Churchill Livingstone, 1983:64-9.
19. Courtney JM, Lamba NMK, Sundaram S, Forbes CD. Biomaterials for blood-contacting applications. Biomaterials 1994;15:737-44.
20. Peerschke EI. Platelet membrane glycoproteins. Functional characterization and clinical applications. Am J Clin Pathol 1992;98:455-63.
21. Faraday N, Goldschmidt-Clermont P, Dise K, Bray PF. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med 1994;123:728-40.
22. Clemetson KJ. Glycoproteins of the platelet plasma membrane. In: George JN, Nurden AT, Phillips DR, eds. Platelet membrane glycoproteins. New York: Plenum Press, 1985:51-85.
23. Michelson AD. Thrombin-induced down-regulation of the platelet membrane glycoprotein Ib-IX complex. Semin Thromb Hemost 1992;18:18-23.
24. Nieuwenhuis HK, van Oosterhout JJ, Rozemuller E, et al. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987;70:838-45.
25. McEver RP, Martin MN. A monoclonal antibody to a membrane glycoprotein binds only on activated platelets. J Biol Chem 1984;259:9799-804.
26. Gawaz M, Bogner C. Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis. Clin Invest 1994;72:424-9.
27. Addonizio W. Platelet function in cardiopulmonary bypass and artificial organs. Hematol Oncol Clin North Am 1990;1:145-55.
28. Ginsberg MH, Loftus JC, Plow EF. Cytoadhesins, integrins, and platelets. Thromb Haemost 1988;59:1-6.
29. Rinder HM, Murphy M, Mitchell JG, et al. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991;31:409-14.
30. Triulzi DJ, Kickler TS, Braine HG. Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis. Transfusion 1992;32:529-33.
31. Holme S, Sweeney JD, Sawyer S, Elfath MD. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss on in vivo viability. Transfusion 1997;37:12-7.
32. Burgstaler EA, Pineda AA, Halling VW. Comparison of platelet CD62 expression of platelets collected by apheresis using three cell separators and platelet rich plasma (abstract). J Clin Apheresis 1995;10:32.
33. Urdahl SG. COBE Spectra apheresis system: designs, protocols and results. Infusionstherapie 1989;16(Suppl):30-43.
34. Musial J, Niewiarowski S, Hershock D, et al. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med 1985;105:514-22.
35. George JN, Picket EB, Saucerman S, et al. Platelet surface glycoproteins: studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986;78:340-8.
36. Rinder CS, Mathew JP, Rinder HM, et al. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991;75:563-70.
37. Bode AP. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 1990;16:109-25; discussion 125-6.
38. George JN. Changes in platelet membrane glycoproteins during blood bank storage. Blood Cells 1992;18:501-11.
39. Storage container for blood components. [World Intellectual Property Organization. Docket #WO 96/15757.] Deerfield, IL: Baxter International, 1996:11-8.
40. Fratantoni JC. Review: The platelet storage lesion: possible role of plasticizers? Blood Cells 1992;18:435-40.
41. Ishikawa Y, Honda K, Sasakawa S, et al. Prevention of leakage of Di-(2-ethylhexyl) phthalate from blood bags by glow discharge treatment and its effect on aggregability of stored platelets. Vox Sang 1983;45:68-76.
42. Gutensohn K, Kuehnl P. The role of flow cytometry in improving biocompatibility in transfusion medicine. Transfus Sci 1998;19:17-25.
43. Snyder EL, Aster RH, Heaton A, et al. Five-day storage of platelets in a non-diethylhexyl phthalate-plasticized container. Transfusion 1992;32:736-41.
44. De Wildt-Eggen J, Schrijver JG, Bouter-Valk HJ, et al. Improvement of platelet storage conditions by using new polyolefin containers. Transfusion 1997;37:476-81.
45. Hogman CF. Aspects of platelet storage. Transfus Sci 1994;15:351-5.